Allander Biotechnologies, Inc. — Form D
Allander Biotechnologies, Inc. of AURORA, CO, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-11. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-10-11
- Form: D
- Accession: 0001997023-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 2
- Date of first sale: 2023-10-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-494440
Issuer
- Name: Allander Biotechnologies, Inc.
- CIK: 0001997023
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 12635 E. MOUNTAINVIEW BLVD. SUITE 100, AURORA, CO, 80045
- Phone: 303-748-3608
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| XiaoJing Wang | Director | AURORA, CO |
| Bing Zhao | Director | Hong Kong, F4 |
| XiaoJing Wang | Executive Officer | AURORA, CO |
More